Skip to content

Understanding What are the pneumonia recommendations for people over 65?

3 min read

According to the Centers for Disease Control and Prevention (CDC), nearly one million older adults are hospitalized with pneumonia each year, making it a serious threat to senior health. Understanding what are the pneumonia recommendations for people over 65 is vital for preventing severe illness and its potentially life-threatening complications.

Quick Summary

For adults 65 and older, current pneumococcal vaccine recommendations typically involve receiving a single dose of either PCV20 or PCV21, or a series starting with PCV15 and followed by PPSV23, depending on prior vaccination history and shared decision-making with a healthcare provider.

Key Points

  • Vaccine Options: The CDC recommends a single dose of PCV20 or PCV21 for most vaccine-naïve seniors, or a series of PCV15 followed by PPSV23.

  • Check Your History: The best vaccination plan depends on your past pneumococcal vaccine history. A doctor can help determine if additional doses are needed.

  • Immunity Boost: Vaccines are crucial for seniors due to weakened immune function and higher risk from chronic conditions.

  • Beyond the Shot: In addition to vaccination, good hygiene, managing chronic diseases, and a healthy lifestyle are key preventive measures.

  • Consult a Professional: Shared clinical decision-making with your healthcare provider is the best way to ensure you receive the most appropriate and up-to-date protection.

In This Article

Why Are Older Adults at Higher Risk?

As people age, their immune systems naturally weaken, a process known as immunosenescence. This decline makes it more difficult for the body to fight off infections, including pneumonia-causing bacteria like Streptococcus pneumoniae. Beyond a weaker immune system, seniors often have other chronic health conditions such as heart disease, lung disease (like COPD), and diabetes, which further increase their vulnerability. The combination of these factors means that pneumonia in older adults can progress more rapidly and lead to more severe outcomes, including hospitalization, sepsis, and a higher mortality rate.

Understanding the Pneumococcal Vaccine Options

In recent years, the vaccine landscape has evolved, with several options available for pneumococcal disease prevention. Your healthcare provider will help you navigate the best choice based on your health history.

  • PCV20 (Prevnar 20®): This pneumococcal conjugate vaccine protects against 20 serotypes of the bacteria. For many vaccine-naïve adults aged 65 and older, a single dose of PCV20 is a complete pneumococcal vaccination series.
  • PCV21 (CAPVAXIVE™): Recently licensed, this 21-valent conjugate vaccine offers protection against additional serotypes. A single dose of PCV21 is also an option for adults for whom a pneumococcal conjugate vaccine is recommended.
  • PCV15 (Vaxneuvance™): This 15-valent conjugate vaccine requires a follow-up dose of PPSV23. If you opt for PCV15, it should be followed by a dose of PPSV23 at least one year later.
  • PPSV23 (Pneumovax™23): The 23-valent polysaccharide vaccine is used in the series with PCV15. It is also an option for those who previously received PCV13, or based on shared clinical decision-making.

Current Recommendations Based on Vaccination History

Your past vaccination history plays a crucial role in determining the right path forward, as outlined by the CDC's Advisory Committee on Immunization Practices (ACIP).

For Vaccine-Naïve Adults (No Previous Pneumococcal Vaccine)

If you have never received a pneumococcal vaccine before turning 65, your options are:

  • A single dose of PCV20 or PCV21. This completes the recommended series.
  • A series involving PCV15, followed by PPSV23 at least one year later.

If You've Previously Received PPSV23 Only

If you received only the PPSV23 vaccine at any age, you should receive a dose of PCV20 or PCV21 at least one year after your last PPSV23 dose.

If You've Previously Received PCV13 Only

If you previously received PCV13, you have a few options, all administered at least one year after your last PCV13 dose:

  • Receive a single dose of PCV20 or PCV21.
  • Receive a single dose of PPSV23.

If You've Previously Received Both PCV13 and PPSV23 (with PPSV23 at age <65)

If you completed this series before age 65, your provider may recommend a single dose of PCV20 or PCV21 at least five years after your last pneumococcal vaccine dose.

Comparison of Key Pneumococcal Vaccines

To help illustrate the options, here is a breakdown of the key vaccines for adults 65 and older.

Vaccine Name Coverage (Serotypes) Standard Regimen for Naïve 65+ Interval before PPSV23 (if needed)
PCV20 20 Single dose; completes series N/A
PCV21 21 Single dose; completes series N/A
PCV15 15 Followed by PPSV23 At least 1 year
PPSV23 23 Follows PCV15 in a series N/A

Additional Prevention Strategies

Vaccination is the most effective way to prevent pneumococcal pneumonia, but it is not the only strategy. Combining vaccination with healthy habits can provide an even stronger defense against infections.

  • Practice Good Hygiene: Regular handwashing is essential. Avoid touching your face and cover your mouth and nose when coughing or sneezing.
  • Stay Up-to-Date on Other Vaccines: Annual flu shots are critical, as influenza can weaken your immune system and make you more susceptible to pneumonia. Staying current with COVID-19 boosters is also advised.
  • Manage Chronic Health Conditions: Properly controlling existing conditions like diabetes, heart disease, and lung disorders can reduce your overall risk of contracting pneumonia.
  • Quit Smoking: Smoking significantly damages your lungs and immune system, increasing your susceptibility to respiratory infections.
  • Adopt a Healthy Lifestyle: Regular exercise, a nutritious diet, and adequate sleep all contribute to a robust immune system.

For more comprehensive guidelines on vaccine safety and schedules, consult the official CDC website.

Conclusion

Making an informed decision about pneumococcal vaccination is a cornerstone of proactive senior health care. With new and updated recommendations, it is more important than ever to discuss your specific history and health profile with your doctor. Whether opting for a single-dose conjugate vaccine or a two-shot series, ensuring your vaccination is current provides a critical layer of protection against the serious threat of pneumonia.

Frequently Asked Questions

As of late 2024, the newest licensed option is PCV21 (CAPVAXIVE™). It is an alternative to PCV20 (Prevnar 20®), which is also a single-dose option for many vaccine-naïve adults over 65.

PCV vaccines (like PCV20, PCV21, and PCV15) are 'conjugate' vaccines that create a stronger, more robust immune response. PPSV23 is a 'polysaccharide' vaccine. For many adults over 65, the updated recommendation simplifies the process by suggesting a single PCV dose.

Yes, pneumococcal vaccines can be safely co-administered with other vaccines, including the annual flu shot. You can receive both during the same visit.

Most side effects are mild and last only a day or two. These can include pain, redness, or swelling at the injection site, fever, headache, and muscle aches.

You may need one or two additional shots, depending on which vaccine you previously received and your current age. A healthcare provider can review your history and advise on the best course of action.

Older adults have naturally weaker immune systems due to age, a process called immunosenescence. They are also more likely to have underlying health conditions like lung or heart disease that increase their risk.

No, the pneumococcal vaccine protects against pneumonia caused by Streptococcus pneumoniae bacteria, which is the most common cause of bacterial pneumonia. It does not protect against all strains or pneumonia caused by viruses or fungi.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.